Sudden Death and Use of Stimulant Medications in Youths
Objective: The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. Method: A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were...
Saved in:
Published in | The American journal of psychiatry Vol. 166; no. 9; pp. 992 - 1001 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Arlington, VA
American Psychiatric Association
01.09.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective:
The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents.
Method:
A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates.
Results:
In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings.
Conclusions:
This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment. |
---|---|
AbstractList | Objective:
The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents.
Method:
A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates.
Results:
In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings.
Conclusions:
This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment. The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents.OBJECTIVEThe authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents.A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates.METHODA matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates.In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings.RESULTSIn 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings.This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment.CONCLUSIONSThis case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment. The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates. In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%). with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings. This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment. The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates. In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings. This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment. |
Author | Gould, Madelyn S. Olfson, Mark Greenhill, Laurence Cooper, Thomas Kleinman, Marjorie Munfakh, Jimmie Lou Walsh, B. Timothy Duan, Naihua |
Author_xml | – sequence: 1 givenname: Madelyn S. surname: Gould fullname: Gould, Madelyn S. – sequence: 2 givenname: B. Timothy surname: Walsh fullname: Walsh, B. Timothy – sequence: 3 givenname: Jimmie Lou surname: Munfakh fullname: Munfakh, Jimmie Lou – sequence: 4 givenname: Marjorie surname: Kleinman fullname: Kleinman, Marjorie – sequence: 5 givenname: Naihua surname: Duan fullname: Duan, Naihua – sequence: 6 givenname: Mark surname: Olfson fullname: Olfson, Mark – sequence: 7 givenname: Laurence surname: Greenhill fullname: Greenhill, Laurence – sequence: 8 givenname: Thomas surname: Cooper fullname: Cooper, Thomas |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21922188$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19528194$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9PwyAYxonR6Jx-haUx0VvnC7RQEi_G_4nGw1yiJ0ILzVg6Wgs9-O1lbu7gxRMh_J73fXieY7TvWmcQmmCYYszZpeo6O1XLbkoAxBQEZJBxsodGOKd5ygkp9tEIAEgqcvp-hI69X8YrUE4O0REWOSmwyEaIzwatjUtujQqLRDmdzL1J2jqZBbsaGuVC8mK0rVSwrfOJdclHO4SFP0EHtWq8Od2eYzS_v3u7eUyfXx-ebq6fU5XRPKQVKVjFCIWSZEXGsK6B6YKazOA87i0Z1KzMuRa8VHXOFFdQg-EEC4EZaEHH6GIzt-vbz8H4IFfWV6aJzkw7eMk4IywraATP_oDLduhd9CYJidlQiMmM0WQLDeXKaNn1dqX6L_mbRwTOt4DylWrqXrnK-h0XfRGCiyJyVxuu6lvve1PLyoafjEKvbCMxyHVNcl2TjDXJdU3yt6YoZ3_kOyf_CelG-PO---E_qm9gWqZr |
CODEN | AJPSAO |
CitedBy_id | crossref_primary_10_1080_10852352_2019_1603672 crossref_primary_10_1007_s00246_013_0810_5 crossref_primary_10_1007_s12024_019_00143_0 crossref_primary_10_1080_09297049_2019_1682131 crossref_primary_10_1080_13651501_2018_1519078 crossref_primary_10_1002_14651858_CD009885_pub2 crossref_primary_10_1016_j_phrs_2010_04_002 crossref_primary_10_5406_amerjpsyc_124_2_0151 crossref_primary_10_1002_pds_4954 crossref_primary_10_1007_s00228_012_1390_7 crossref_primary_10_1016_j_addbeh_2015_10_007 crossref_primary_10_1007_s12402_012_0072_8 crossref_primary_10_1016_j_jaac_2013_09_001 crossref_primary_10_1176_appi_ajp_2009_09101388 crossref_primary_10_1016_j_jaac_2011_07_018 crossref_primary_10_1176_appi_ajp_2009_09101389 crossref_primary_10_1017_S1461145711000095 crossref_primary_10_4137_CMPed_S7868 crossref_primary_10_1007_s00406_014_0522_8 crossref_primary_10_1097_YIC_0000000000000288 crossref_primary_10_1007_s15202_015_0673_0 crossref_primary_10_1038_s41390_018_0256_9 crossref_primary_10_1016_j_hjc_2022_06_005 crossref_primary_10_1080_14740338_2017_1301928 crossref_primary_10_1007_s12402_012_0087_1 crossref_primary_10_5765_jkacap_2017_28_2_70 crossref_primary_10_1177_0009922810397887 crossref_primary_10_3390_healthcare7020055 crossref_primary_10_1016_j_acap_2016_03_011 crossref_primary_10_1016_j_euroneuro_2010_06_011 crossref_primary_10_1016_j_mehy_2012_04_049 crossref_primary_10_1007_s11126_013_9253_7 crossref_primary_10_1007_s40263_019_00686_4 crossref_primary_10_1093_ehjcvp_pvad028 crossref_primary_10_1097_PCC_0000000000000506 crossref_primary_10_1016_j_chc_2022_02_002 crossref_primary_10_1093_pch_14_9_586 crossref_primary_10_1891_EHPP_2022_0011 crossref_primary_10_1111_jce_12744 crossref_primary_10_1007_s00246_012_0516_0 crossref_primary_10_1186_s40199_015_0092_y crossref_primary_10_1016_j_drugalcdep_2013_04_024 crossref_primary_10_1515_ijamh_2019_0174 crossref_primary_10_1007_s00112_010_2219_z crossref_primary_10_1007_s13158_012_0064_z crossref_primary_10_15844_pedneurbriefs_25_12_1 crossref_primary_10_1016_j_jaac_2011_11_008 crossref_primary_10_1517_14740338_2010_503238 crossref_primary_10_1016_j_yapd_2010_08_004 crossref_primary_10_1097_MOP_0b013e328357a7c3 crossref_primary_10_1111_j_1600_0447_2010_01607_x crossref_primary_10_1016_j_pnpbp_2012_05_021 crossref_primary_10_1891_1559_4343_14_1_5 crossref_primary_10_1093_pch_14_9_579 crossref_primary_10_1161_CIR_0b013e3181d98555 crossref_primary_10_1007_s40263_012_0019_9 crossref_primary_10_1161_CIRCULATIONAHA_110_017228 crossref_primary_10_1002_pds_4164 crossref_primary_10_1161_CIRCULATIONAHA_109_901256 crossref_primary_10_1002_pds_4041 crossref_primary_10_1007_s12152_018_9389_0 crossref_primary_10_1542_peds_2019_2528 crossref_primary_10_1016_j_cll_2012_06_006 crossref_primary_10_1176_appi_ajp_2009_09050619 crossref_primary_10_1016_j_psychsport_2011_12_007 crossref_primary_10_1016_j_arcped_2013_11_001 crossref_primary_10_1517_14740338_2015_1011620 crossref_primary_10_1056_NEJMoa1110212 crossref_primary_10_1177_21676968221116544 crossref_primary_10_1007_s00103_010_1105_0 crossref_primary_10_1016_j_childyouth_2012_01_011 crossref_primary_10_1136_ebmental_2018_300040 crossref_primary_10_1007_s00391_017_1351_y crossref_primary_10_1521_capn_2013_18_4_1 crossref_primary_10_1177_0009922810368289 crossref_primary_10_1586_ern_09_128 crossref_primary_10_1016_j_cpr_2012_11_005 crossref_primary_10_1176_appi_ajp_2009_09091292 crossref_primary_10_1089_cap_2015_0264 crossref_primary_10_1515_jpem_2022_0344 crossref_primary_10_1007_s00431_018_3281_0 crossref_primary_10_1016_j_labeco_2016_05_018 crossref_primary_10_1097_CRD_0000000000000234 crossref_primary_10_1177_1087054712455504 crossref_primary_10_1016_j_neurenf_2010_02_004 crossref_primary_10_1176_appi_ajp_2011_11010125 crossref_primary_10_1177_0093854812437015 crossref_primary_10_1002_14651858_CD012069_pub2 crossref_primary_10_1007_s40263_017_0410_7 crossref_primary_10_1111_jcpp_12036 crossref_primary_10_1186_2193_1801_3_286 crossref_primary_10_1016_j_yrtph_2015_04_022 crossref_primary_10_1176_appi_ajp_2011_10111705 crossref_primary_10_1089_cap_2018_0052 crossref_primary_10_2139_ssrn_4883850 crossref_primary_10_2165_11532570_000000000_00000 crossref_primary_10_1111_bcp_12474 crossref_primary_10_1007_s00787_010_0140_6 crossref_primary_10_1097_FAD_0000000000000019 crossref_primary_10_1016_j_jaac_2011_11_013 crossref_primary_10_5402_2012_170935 crossref_primary_10_1002_pds_1992 crossref_primary_10_1038_clpt_2010_82 crossref_primary_10_1017_S1047951111000928 crossref_primary_10_1891_EHPP_D_20_00024 crossref_primary_10_1080_14740338_2017_1389894 crossref_primary_10_1136_bmjpo_2024_002753 crossref_primary_10_1007_s00246_012_0162_6 crossref_primary_10_1016_S0246_1072_12_53147_0 crossref_primary_10_1016_S0828_282X_09_70157_6 crossref_primary_10_3389_fnins_2022_1020961 crossref_primary_10_3109_15563651003720234 crossref_primary_10_1007_s15014_015_0314_2 crossref_primary_10_1055_s_0032_1305091 crossref_primary_10_1080_14681366_2019_1624599 crossref_primary_10_1016_j_addbeh_2015_01_022 crossref_primary_10_1542_peds_2019_2832 crossref_primary_10_1097_MED_0000000000000587 crossref_primary_10_1007_s10840_012_9755_5 crossref_primary_10_1186_1471_2261_12_41 crossref_primary_10_1007_s00787_018_1217_x crossref_primary_10_1007_s11906_019_0968_1 crossref_primary_10_1016_j_euroneuro_2012_06_011 crossref_primary_10_1016_S0084_3954_09_79647_2 crossref_primary_10_1177_1534650112440741 crossref_primary_10_1542_peds_2011_1574 crossref_primary_10_1089_cap_2015_0239 crossref_primary_10_1586_ern_11_175 crossref_primary_10_1016_S0140_6736_19_33004_1 crossref_primary_10_1111_jpc_16380 crossref_primary_10_1016_j_explore_2010_02_001 crossref_primary_10_1590_S1516_44462009000400022 crossref_primary_10_3345_cep_2021_01466 crossref_primary_10_1016_j_pcl_2010_10_009 crossref_primary_10_1007_s12618_009_0018_z crossref_primary_10_1016_j_jacc_2020_05_081 crossref_primary_10_1097_MOP_0000000000000388 crossref_primary_10_1007_s40272_012_0001_5 crossref_primary_10_3280_RSF2016_002006 crossref_primary_10_1089_cap_2011_0141 crossref_primary_10_1016_j_childyouth_2010_10_006 crossref_primary_10_1177_0269881111405356 crossref_primary_10_1542_peds_2010_3371 crossref_primary_10_2174_1574886317666220525115232 crossref_primary_10_1016_j_ahj_2012_07_019 crossref_primary_10_1002_pds_2348 crossref_primary_10_1542_peds_2011_2654 |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS Copyright American Psychiatric Association Sep 2009 |
Copyright_xml | – notice: 2009 INIST-CNRS – notice: Copyright American Psychiatric Association Sep 2009 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 |
DOI | 10.1176/appi.ajp.2009.09040472 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) ProQuest Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-7228 |
EndPage | 1001 |
ExternalDocumentID | 1852634001 19528194 21922188 10_1176_appi_ajp_2009_09040472 10.1176/appi.ajp.2009.09040472 |
Genre | Journal Article Comparative Study Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: R01-MH56250 |
GroupedDBID | --- --Z -DZ -~X .55 .GJ 08P 0WA 1CY 1HT 1KJ 1QT 23M 2QL 2WC 354 3O- 4.4 41~ 53G 5GY 5RE 6J9 6TJ 7K8 85S 8F7 8R4 8R5 AAAHA AAIKC AAJMC AAJWC AAKAS AAMNW AAQQT AAWTL AAWTO AAYJJ ABIVO ABPPZ ABZEH ACBMB ACGFO ACGOD ACHQT ACNCT ADBBV ADCOW ADZCM AENEX AERZD AETEA AFAZI AFFDN AFFNX AFMIJ AFOSN AGHSJ AGNAY AHJKT AHMBA AI. AIZTS ALMA_UNASSIGNED_HOLDINGS ASUFR BAJDF BAWUL BCR BENPR BKOMP BLC CS3 DIK E3Z EBS EJD EX3 F20 F5P F8P FA8 FJW G0H G8K GOZPB GRPMH HF~ HZ~ J5H L7B LPU LXL LXN MVM N4W N9A NEJ NHB OHT OK1 OVD P-O P2P PEA PQQKQ Q.- Q2X RAY RWL RXW RYA S10 SJN SKT TAE TEORI TR2 TWZ UBC UHB UKR ULE UPT UQL VH1 VVN WH7 WHG WOQ WOW X4V X6Y X7M XJT XOL XSW XZL YCJ YFH YOC YQI YQJ YRY YSK YWH YXB YYQ YZZ ZCA ZGI ZHY ZKB ZRR ZXP ZY1 ~A~ ~G0 ~X8 AAYXX ABDPE ADGHP ADMHG CITATION H13 IQODW CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-a435t-c286c6230b248461df06d83e4e15ddeb60f6b57d97baf56a7a0f0e72199160d93 |
ISSN | 0002-953X 1535-7228 |
IngestDate | Fri Jul 11 09:24:34 EDT 2025 Mon Jun 30 05:41:26 EDT 2025 Mon Jul 21 05:43:32 EDT 2025 Wed Apr 02 07:36:10 EDT 2025 Tue Jul 01 01:51:34 EDT 2025 Thu Apr 24 22:58:28 EDT 2025 Wed Jul 24 08:10:55 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Cardiovascular disease Cardiocirculatory arrest CNS stimulant Psychotropic Sudden death |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a435t-c286c6230b248461df06d83e4e15ddeb60f6b57d97baf56a7a0f0e72199160d93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 |
PMID | 19528194 |
PQID | 220473015 |
PQPubID | 40661 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_67626483 proquest_journals_220473015 pubmed_primary_19528194 pascalfrancis_primary_21922188 crossref_citationtrail_10_1176_appi_ajp_2009_09040472 crossref_primary_10_1176_appi_ajp_2009_09040472 appi_journals_10_1176_appi_ajp_2009_09040472 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-09-01 |
PublicationDateYYYYMMDD | 2009-09-01 |
PublicationDate_xml | – month: 09 year: 2009 text: 2009-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Arlington, VA |
PublicationPlace_xml | – name: Arlington, VA – name: United States – name: Washington |
PublicationTitle | The American journal of psychiatry |
PublicationTitleAlternate | Am J Psychiatry |
PublicationYear | 2009 |
Publisher | American Psychiatric Association |
Publisher_xml | – name: American Psychiatric Association |
References | 20123922 - Am J Psychiatry. 2010 Feb;167(2):213-4; author reply 214-5 20123924 - Am J Psychiatry. 2010 Feb;167(2):214; author reply 214-5 19528196 - Am J Psychiatry. 2009 Sep;166(9):955-7 20123923 - Am J Psychiatry. 2010 Feb;167(2):213; author reply 214-5 |
References_xml | – reference: 20123924 - Am J Psychiatry. 2010 Feb;167(2):214; author reply 214-5 – reference: 19528196 - Am J Psychiatry. 2009 Sep;166(9):955-7 – reference: 20123922 - Am J Psychiatry. 2010 Feb;167(2):213-4; author reply 214-5 – reference: 20123923 - Am J Psychiatry. 2010 Feb;167(2):213; author reply 214-5 |
SSID | ssj0000372 |
Score | 2.4053884 |
Snippet | Objective:
The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained... The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in... |
SourceID | proquest pubmed pascalfrancis crossref appi |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 992 |
SubjectTerms | Accidents, Traffic - mortality Accidents, Traffic - statistics & numerical data Adolescent Adolescent Behavior - psychology Adult Age Distribution Attention deficit hyperactivity disorder Biological and medical sciences Case-Control Studies Cause of Death Central Nervous System Stimulants - adverse effects Central Nervous System Stimulants - therapeutic use Child Child & adolescent psychiatry Children & youth Coroners and Medical Examiners - statistics & numerical data Death Certificates Death, Sudden - epidemiology Dextroamphetamine - adverse effects Drug therapy Fatalities Female Humans Logistic Models Male Medical sciences Methamphetamine - adverse effects Methylphenidate - adverse effects Mortality Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Risk Factors Stimulants United States - epidemiology |
Title | Sudden Death and Use of Stimulant Medications in Youths |
URI | http://dx.doi.org/10.1176/appi.ajp.2009.09040472 https://www.ncbi.nlm.nih.gov/pubmed/19528194 https://www.proquest.com/docview/220473015 https://www.proquest.com/docview/67626483 |
Volume | 166 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqISEkhPheGYw88AZhiRM7ySOgTWO042GtKE-R7dhSRptWbfIAfwp_LefY-dIGA16iKpZTx3f5-c6-ux9CrzjnQoiEuREsF25ImXQZ8YUbKuXzDHMSJTpReHpOT-fh2YIsRqOfvailquRvxY9r80r-R6pwD-Sqs2T_QbLtQ-EG_Ab5whUkDNe_kvFFpWEDMIPZBLW52Zm_KPNVtYQ5s-cwbbz4V02Yt-sbpLMus6Tol5EYRkGbCvqWDHuqK0t-L7pN0y_wovXuzPtG9J0YC8W-1W1n-WqVy9eTddVi_FLmhd2AnbLt5Xqby8EmRBdlVfbi_hvUNgwjV_SrQ-CE1BzAsP40oKspdW2SeIPKhozFql_Sw9jEkOddxf6oLnq80TmAl00p0gRAKjTkQMNi2-ef05P5ZJLOjhezYavxjWKCaQAAB571LQwuSO2uf_zUrfJBhBvXSr-PzT6HQRxdPwRY83XDwP65u2E7-BSV4VD5vZNTGzuz--ie9VKcd0blHqCRLB6i21Mbh_EIRUbznFrzHNA8BzTPWSun1Tynp3lOXjhG8x6j-cnx7MOpayk4XAZ2dOkKHFMBFrLHcQiWqp8pj2ZxIEPpE_gfTj1F4XvOkogzRSiLmKc8GWEdUEe9LAmeoL1iXch95AQiwAorTgSVIYtw7CsmfJUoxcHpF3SM3uj5Sa2q79LaPY1oWt-F6dSMqUnaTOcYkWYeU2HL2WtWleWN_Y7afhtT0OXGHocDMbXd4C0xWMjxGB00cutGjzH0hdWTjNHLthWgW5_HsUKuq11KwRChYRyM0VMj7G5ACdEH3OGzPz75AN3pvsXnaK_cVvIFmMglP6x19Rd-87qi |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sudden+Death+and+Use+of+Stimulant+Medications+in+Youths&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Gould%2C+Madelyn+S&rft.au=Walsh%2C+B+Timothy&rft.au=Munfakh%2C+Jimmie+Lou&rft.au=Kleinman%2C+Marjorie&rft.date=2009-09-01&rft.pub=American+Psychiatric+Association&rft.issn=0002-953X&rft.eissn=1535-7228&rft.volume=166&rft.issue=9&rft.spage=992&rft_id=info:doi/10.1176%2Fappi.ajp.2009.09040472&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=1852634001 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-953X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-953X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-953X&client=summon |